BEAM

DRUG8 trials

Conditions

Autologous Stem Cell TransplantationConditioningDLBCLEmotional DistressHodgkin DiseaseHodgkin LymphomaLymphomaLymphoma, Follicular

Phase 1

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

CompletedNCT00572013

University of NebraskaLymphoma

Start: 1998-05-12End: 2009-09-18Updated: 2023-09-07

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

CompletedNCT00574509

University of NebraskaLymphoma

Start: 1996-03-04End: 2014-12-10Updated: 2023-10-10

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

TerminatedNCT01468311

National Cancer Institute (NCI)Hodgkin Disease, Hodgkin Lymphoma

Start: 2011-10-11End: 2020-10-22Updated: 2021-10-06

Phase 2

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

CompletedNCT02278796

Insel Gruppe AG, University Hospital BernLymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Start: 2015-04-30End: 2020-11-30Updated: 2025-08-01

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Not yet recruitingNCT06652165

Ruijin HospitalDLBCL

Start: 2024-11-01End: 2028-11-01Target: 66Updated: 2024-10-22

Phase 3

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

CompletedNCT01827605

Fondazione Italiana Linfomi - ETSRelapsed Follicular Lymphoma

Start: 2012-01-01End: 2024-01-01Updated: 2026-09-09

Unknown Phase

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

NCT05814718

First Affiliated Hospital Xi'an Jiaotong UniversityAutologous Stem Cell Transplantation, Conditioning

Start: 2023-04-15End: 2025-12-31Target: 122Updated: 2023-04-18

Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM)

Active, not recruitingNCT06713460

Consorci Sanitari de TerrassaEmotional Distress

Start: 2025-04-07End: 2026-12-30Updated: 2026-05-14

Related Papers

Increased incidence of secondary malignancies after autologous stem cell transplantation in follicular lymphoma patients: Long-term results of the FIL-FLAZ12 Phase III randomized trial

Blood2025-11-03

BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial.

2023-11-192 citations

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.

2023-11-035 citations

P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA: A FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III TRIAL.

HemaSphere2022-06-01